ProductLife Group enhances clinical safety expertise with Stragen Services acquisition
Deal News | Jan 28, 2025 | Globenewswire
ProductLife Group (PLG), an international consultancy focused on regulatory science, compliance, and digital transformation, has announced the acquisition of Stragen Services, a division of Stragen Group, with backing from international investment firm ARCHIMED. Stragen Services, based in Lyon and founded in 2009, is known for its clinical safety and pharmacovigilance expertise, servicing biotech and pharmaceutical communities. This acquisition aims to bolster PLG's leadership in pharmacovigilance across French and European markets, enhancing its ability to deliver globally recognized compliance and safety support. Stragen Services' seasoned team of 36 employees will join PLG to provide tailored pharmacovigilance solutions worldwide, reflecting shared values of client-centric excellence. Leadership from PLG, including CEO Xavier Duburcq, is optimistic about leveraging Stragen Services' expertise to strengthen market positioning. Jean-Yves Desmottes from ARCHIMED affirms the acquisition as a strategic step for growing Stragen Services' premium service offerings. The move reflects PLG's commitment to sustaining high excellence standards and long-term partnerships in a complex healthcare landscape.
Sectors
- Healthcare and Life Sciences
- Private Equity
Geography
- France – France is relevant as both ProductLife Group and Stragen Services operate within the French market, with Stragen Services being based in Lyon.
- Europe – The article discusses ProductLife Group's expanded capabilities in Europe resulting from the acquisition, emphasizing its strategic importance within the broader regional market.
Industry
- Healthcare and Life Sciences – This sector is relevant as the article involves companies that provide services related to regulatory compliance and pharmacovigilance in the life sciences arena.
- Private Equity – This sector is relevant because the acquisition is supported by ARCHIMED, a private equity firm.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ProductLife Group | Acquirer | Company | An international consultancy offering regulatory, compliance, and digital transformation services in the life sciences sector. |
| Stragen Services | Target Company | Company | A division of Stragen Group specializing in clinical safety and pharmacovigilance services. |
| Stragen Group | Vendor | Company | The parent company of Stragen Services, involved in developing generic products. |
| ARCHIMED | Investor | Company | An international private investment firm supporting the acquisition. |
| Stéphanie Collomb Gilbert | Director General of Stragen Services | Person | Expressed strategic alignment with ProductLife Group's values and objectives. |
| Xavier Duburcq | CEO of ProductLife Group | Person | Highlighted the acquisition's importance in consolidating PLG's market leadership. |
| Jean-Yves Desmottes | Partner at ARCHIMED | Person | Participated in the transaction to support the growth and service expansion of Stragen Services. |